Now Available:
Watch video podcasts of press conference footage from ACR 2008

MSK Report provides cutting-edge scientific updates through biweekly and special edition newsletters, in-depth interviews, and on-location coverage of medical meetings. With an editorial board of internationally recognized thought leaders, MSK Report is positioned to provide unparalleled quality news reporting with the highest level of credibility.

Upcoming CME Opportunities:

Procedures: Forget Knee OA Glucosamine, Orthotics—Lose Weight, AAOS Says
New knee arthritis guidelines from the premier American orthopaedics society say that glucosamine and/or chondroitin, custom-made shoe foot orthotics, and needle lavage are basically useless for the treatment of knee OA, but losing weight helps...

Consumer News: Study Links Osteoporosis Drugs to Jaw Trouble
People taking oral osteoporosis drugs may have a higher risk of developing jaw trouble than previously thought...

BioPharm Business: BioMarin Bets $289 Million That Riquent Works in Lupus Nephritis
BioMarin has bet $289 million that the third time is the charm for La Jolla Pharmaceutical's experimental lupus drug Riquent (abetimus sodium), which failed to reach primary endpoints in 2 previous clinical trials...

Click here to remove your e-mail address from our mailing list. For questions and comments regarding this newsletter please contact info@mskreport.com.